# Memantine Therapy in Amyotrophic Lateral Sclerosis

> **NCT01020331** · PHASE2 · COMPLETED · sponsor: **Phoenix Neurological Associates, LTD** · enrollment: 20 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT01020331
- **Lead sponsor:** Phoenix Neurological Associates, LTD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020331, "Memantine Therapy in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01020331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*